Ionis Pharmaceuticals’ $632.5 Million Convertible Senior Notes Offering

Davis Polk advised the representatives of the several purchasers in offering.Ionis Pharmaceuticals, Inc. executed its offering of an aggregate principal amount of $632.5 million of its 0%…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now